# Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/johnson-johnson-pharmaceutical-research-development-llc/64f5e129-7429-4c6c-b7e9-ab46acc01ab7

> Inspection records and compliance data for Johnson & Johnson Pharmaceutical Research & Development, LLC in Raritan, New Jersey. 6 FDA inspections on record, last inspected June 30, 2011.

---

## Details

- Name: Johnson & Johnson Pharmaceutical Research & Development, LLC
- FEI Number: 3006192174
- Address Line 1: 920 U.S. Highway 202, P.O. Box 300
- City: Raritan
- State: New Jersey
- Zip Code: 08869
- Country Name: United States
- Address: 920 U.S. Highway 202, P.O. Box 300, Raritan, New Jersey 08869, United States
- Country: United States

## Related Documents

- FDA Inspection 734553 - Johnson & Johnson Pharmaceutical Research & Development, LLC - 2011-06-30 — classification: No Action Indicated (NAI), source: FDA, date: June 30, 2011
- FDA Inspection 721726 - Johnson & Johnson Pharmaceutical Research & Development, LLC - 2011-04-12 — classification: No Action Indicated (NAI), source: FDA, date: April 12, 2011
- FDA Inspection 676520 - Johnson & Johnson Pharmaceutical Research & Development, LLC - 2010-08-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 20, 2010
- [FDA Inspection 575843 - Johnson & Johnson Pharmaceutical Research & Development, LLC - 2009-04-14](https://www.keypedia.com/records/fda_inspections/johnson-johnson-pharmaceutical-research-development-llc/cfadf839-d974-4136-a2b5-337bd356d91c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 14, 2009
- FDA Inspection 572206 - Johnson & Johnson Pharmaceutical Research & Development, LLC - 2009-03-27 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 27, 2009
- FDA Inspection 573200 - Johnson & Johnson Pharmaceutical Research & Development, LLC - 2009-03-24 — classification: No Action Indicated (NAI), source: FDA, date: March 24, 2009

## Related Companies

- [Package Development Co., Inc.](https://www.keypedia.com/companies/package-development-co-inc/6aee1fe1-9bf9-42d2-963b-49504779e771)
- [Optimer Pharmaceuticals](https://www.keypedia.com/companies/optimer-pharmaceuticals/39201b47-7a62-4bdf-9b7d-0cba73e3ef1f)
- [Complete Analysis Laboratories Inc](https://www.keypedia.com/companies/complete-analysis-laboratories-inc/84b3c349-8ace-45a3-bb08-ad79056d999a)
- [Oxygen Supply Company, Inc.](https://www.keypedia.com/companies/oxygen-supply-company-inc/2012eb7b-86d4-4929-9e46-04f14cd96088)
- [The Pharma Network, LLC](https://www.keypedia.com/companies/the-pharma-network-llc/c79baf11-f248-494b-887b-a5d104f77521)
- [Turning Point Therapeutics Inc](https://www.keypedia.com/companies/turning-point-therapeutics-inc/8f92fd36-d0b9-4a15-9bfd-a1cb65e19974)
- [Pearl Therapeutics, Inc.](https://www.keypedia.com/companies/pearl-therapeutics-inc/58938004-d2e7-43fc-a949-7a37ed11741a)
- [Goldberg, Stuart L. M.D.](https://www.keypedia.com/companies/goldberg-stuart-l-md/d0651dee-a15b-4ae4-8820-5485c0e2061c)
- [Chanel Inc](https://www.keypedia.com/companies/chanel-inc/61255609-211f-4992-a5ce-4e769cade871)
- [Jeffrey T. Apter, M.D.](https://www.keypedia.com/companies/jeffrey-t-apter-md/95ebce37-6030-42af-abad-78deb1f256a4)